Marc Scheineson will be speaking at the Advertising and Promotion for Medical Products Conference, sponsored by the Food & Drug Law Institute (FDLI). The conference will analyze the latest commercial issues related to advertising and promotion of human and animal drugs, medical devices, and biologics.
Marc’s panel, “FDA-FTC Review of Biosimilars Promotion,” will cover the FDA and FTC review process for biosimilar promotion in the marketplace.
For more information, click here.